Get App
Location
Location

Consult Dr Sahil Bambroo Online Oncology

Dr Sahil Bambroo
₹ 600.00

Dr Sahil Bambroo tested

Oncology

DM (Medical Oncology), MD (General Medicine), MBBS

12yr experience map Greater Noida

comments Hindi, English, Kashmiri, Malayalam, Kannada, Punjabi, Urdu

About the doctor

Profile Description

Dr. Sahil Bambroo is a highly trained Medical Oncologist with extensive experience in the diagnosis and treatment of various cancers. He completed his MBBS and MD in General Medicine before further specializing with a DM in Medical Oncology from the prestigious Amrita Institute of Medical Sciences, Kochi. Dr. Bambroo is currently a Consultant Medical Oncologist at Kailash Hospital Noida and Greater Noida, a position he has held since September 2020. Previously, he served as an Assistant Professor in the Department of Medical Oncology and Haematology at Amrita Institute of Medical Sciences from September 2019 to September 2020 and as a Senior Resident at the same institution from August 2016 to August 2019. He also held a Senior Resident position at Pushpawati Singhania Research Institute in Delhi in June 2016.

Dr. Bambroo specializes in the treatment of various types of cancers, including breast cancer, gynecological malignancies, lung cancer, hematological malignancies, gastrointestinal and hepatobiliary cancers, as well as genitourinary and prostate cancers. His areas of expertise also include preventive oncology, community-level cancer detection, molecular profiling of cancers, and the use of immunotherapy and targeted therapies in cancer treatment.

He has authored several scientific papers published in national and international journals and is a distinguished speaker at various medical conferences. Dr. Bambroo is committed to advancing cancer care through personalized, evidence-based approaches and is dedicated to improving patient outcomes.

Qualifications

DM (Medical Oncology), MD (General Medicine), MBBS

Awards and Recognitions

    -Observership in Henry Ford Health System, Detroit, Michigan, USA (May 2018)
    -Second prize in Quiz, ONCOLOGY 2018 – Multidisciplinary management of common cancers, 2018
    -Second prize in Poster – Analysis of EGFR 18, 19 and EGFR vIII over-expression in GBM and its prognostic -significance – a single centre experience, ISNOCON 2018, AIIMS Delhi, 2018
    -Aswath Ram Jaya Nazir’ award for securing highest marks in Preventive and Social Medicine, 2009

Research & Publications

    Adherence to Antiemesis Guidelines in a Day Care Chemotherapy Unit: Experience from a Tertiary Care Centre; Indian Journal of Applied Research, Volume-9 | Issue-12 | December - 2019 | PRINT ISSN No. 2249 - 555X | DOI : 10.36106/ijar PRESENTATIONS • Paper presentation - Analysis of BRAF V600E mutation in central nervous system in a tertiary cancer centre in India, ISNOCON, Bhopal (April 2019) • Paper presentation – Renal Failure in Multiple Myeloma, A single centre experience, International Update on Plasma cell dyscrasias, KMIO, Bengaluru (11-12 February 2017) • Paper presentation – Rituximab - Bendamustine in treatment for Follicular Lymphoma, API Kerala Chapter, Quarterly Meeting, Perinthalmanna, Kerala (30 October 2016) • Paper presentation - A rare case of Vibrio vulnificus – Back water disease at Association of Physicians of India – Kerala Chapter, Thiruvananthapuram (9 March 2014 • Poster – Extranodal Lymphomas – A single centre experience : LYMPHOCON 2019 – An International update on Lymphomas, Department of Medical Oncology, Kidwai cancer Institute, Bengaluru and KMIO Medical Oncologists Alumni Association (12-13 January 2019) • Poster – Effect of Melphalan 200 v/s lesser doses in toxicities in patients with multiple myeloma undergoing single autologous stem cell transplantation: HAEMATOCON 2018, Indian Society of Haematology and Blood Transfusion (25-28 October, 2018) • Poster – Tamoxifen induced macular hole, Indian Breast cancer conference, Jaipur (5-7 October, 2018) • Poster – Analysis of EGFR 18, 19 and EGFR vIII over-expression in GBM and its prognostic significance – a single centre experience, ISNOCON 2018, AIIMS Delhi (5-8 April 2018) • Poster - Systems Oncology 2017, Kochi (10-12 March 2017) • Poster – Role of Vitamin C in treatment of Methemoglobinemia : a case series, at Amrita Hematocon 2014 held at AIMS, Kochi on 18 January 2014

Services

Medical Conditions Treated:

Services

    • Breast Cancer,
    • Lung Cancer,
    • Prostate Cancer,
    • Colorectal Cancer,
    • Leukemia,
    • Lymphoma,
    • Pancreatic Cancer,
    • Ovarian Cancer,
    • Skin Cancer,
    • Brain Tumor,
    • Medical Oncology,
    • Hematology,
    • Chemotherapy,
    • Immunotherapy,
    • Diagnosis and treatment of solid and hematological malignancies leukemia,
    • Lymphoma,
    • Blood-forming tissue immune system problems on joints muscles,
    • Bones and organs,
    • Autoimmune and inflammatory diseases

Other doctors for “Oncology

Dr Ram Prahlad
₹ 500.00

Dr Ram Prahlad tested

Oncology

MD, DM (Medical Oncology), MBBS

15yr experience map Hyderabad

comments English, Hindi, Telugu

Dr Ravi Narra
₹ 1,350.00

Dr Ravi Narra tested

Oncology

MD, MS, Hematology, Medical Oncology (USA)

12yr experience map Milwaukee

comments English, Hindi, Telugu

Dr Poovamma Uthappa
₹ 650.00

Dr Poovamma Uthappa tested

Oncology

MS

12yr experience map Bangalore

comments English, Hindi, Kannada, Tamil

FAQ’s

The consultation fee for an online doctor consultation with Dr. Sahil Bambroo is ₹600.

Appointments with Dr. Sahil Bambroo can be easily scheduled through Medicas, offering convenient access to his oncology services.

Dr. Sahil Bambroo is currently practicing at Kailash Hospital in Noida and Greater Noida, Uttar Pradesh.

Dr. Bambroo holds an MBBS, MD in General Medicine, and DM in Medical Oncology from Amrita Institute of Medical Sciences, Kochi.

Dr. Bambroo speaks Hindi, English, Kashmiri, Malayalam, Kannada, Punjabi, and Urdu.

Patients consult Dr. Bambroo for a wide range of cancers, including breast cancer, gynecological malignancies, lung cancer, hematological malignancies, gastrointestinal and hepatobiliary cancers, and genitourinary and prostate cancers. He also specializes in preventive oncology, molecular profiling, and the use of immunotherapy and targeted therapies for cancer treatment.